US equities |
NVDA $238.55 ▲+1.97% SPCX $167.63 ▲+5.45% MU $1,062.61 ▼-1.14% TSLA $380.11 ▲+2.57% MSFT $525.93 ▲+1.62% SNDK $1,703.40 ▼-0.96% INTC $117.14 ▼-1.84% META $742.92 ▲+2.04%
FinancialContent

Articles published by Kashiv Biosciences LLC

News headline image
Kashiv BioSciences Enters into Exclusive Licensing Agreement with Alvotech for Development & Commercialization of a Proposed Biosimilar to Xolair® (omalizumab)
From Kashiv Biosciences LLC
Via Business Wire
Tickers ALVO